Eli Lilly (LLY.US) announces the establishment of a new pharmaceutical factory in Texas, USA, to increase production of weight loss drugs to meet the surge in demand.

Zhtng Cijng APP hud, zh yo jtu lli (LLY.US) zhur xunb, jing tuz 65 y miyun zi migu dkss zhu xisdn jinsh yzu qunxn shngchn shsh, y kud q xio fnz yow chnnng, zhngdin yngy shngchn bishu shchng gunzh de shyn xng kuf jinfi yo orforglipron. According to the Wise Finance APP, pharmaceutical giant Eli Lilly (LLY.US) announced on Tuesday that it will invest 6.5 billion US dollars to build a new production facility in Houston, Texas, USA, to expand its small molecule drug production capacity, focusing on the production of the market-touted experimental oral weight loss drug orforglipron.